BJ Sullivan

BJ leads cross-functional strategic and operational projects at BioAge, partnering closely with the company's executive team. Previously, BJ was a Manager in the Life Sciences practice at L.E.K. Consulting, where he supported biopharma and diagnostics clients in growth strategy and M&A. Key accomplishments at L.E.K. include diligence efforts that culminated in a ~$75B acquisition—one of the largest healthcare transactions in history—followed by integration planning and development of a roadmap to immunology leadership for the NewCo. BJ received an undergraduate degree in Molecular Biology from Princeton University and a PhD in Molecular & Medical Pharmacology from the UCLA School of Medicine, where his research resulted in a first-author publication in Cell.